ARN-509 in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with abiraterone acetate (AA) Meeting Abstract


Authors: Rathkopf, D. E.; Antonarakis, E. S.; Shore, N. D.; Tutrone, R.; Alumkal, J. J.; Ryan, C. J.; Saleh, M. N.; Hauke, R. J.; Bandekar, R.; Maneval, E. C.; de Boer, C.; Todd, M.; Yu, M. K.; Scher, H. I.
Abstract Title: ARN-509 in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with abiraterone acetate (AA)
Meeting Title: 105th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 74
Issue: 19 Suppl.
Meeting Dates: 2014 Apr 5-9
Meeting Location: San Diego, CA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2014-10-01
Language: English
ACCESSION: WOS:000349910205065
DOI: 10.1158/1538-7445.am2014-ct239
PROVIDER: wos
Notes: Meeting Abstract: CT239 -- 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 05-09, 2014 -- San Diego, CA -- S -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dana Elizabeth Rathkopf
    276 Rathkopf
  2. Howard Scher
    1133 Scher